glutathione s transferase alpha Overexpression of S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications Glutathione S Transferase Alpha 1

Key Highlights from REIMAGINE 13 REIMAGINE 1 (Diet & Exercise Alone) 40 Weeks HbA1c reduction: 1.8% Weight loss: 13.8% Baseline HbA1c: 7.8% REIMAGINE 2 (Metformin SGLT2 Inhibitor) 68 Weeks HbA1c reduction: 1.91% Weight loss: 14.2% Demonstrated superiority over semaglutide 2.4 mg: * HbA1c: 1.91% vs 1.75% * Weight loss: 14.2% vs 10.2% REIMAGINE 3 (Add-on to Basal Insulin) 40 Weeks HbA1c reduction: 2.33% Weight loss: 12.0% Achieved meaningful metabolic improvements despite background insulin therapy

Baltimore: Williams and Wilkins, 1976., p

2023;173:e57885

Understanding the practical considerations of switching helps prevent common mistakes during transitions